SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-077388
Filing Date
2012-11-13
Accepted
2012-11-13 16:13:06
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20046_110q.htm 10-Q 780346
2 EX-31.1 a12-20046_1ex31d1.htm EX-31.1 9629
3 EX-31.2 a12-20046_1ex31d2.htm EX-31.2 9604
4 EX-32.1 a12-20046_1ex32d1.htm EX-32.1 4479
5 EX-32.2 a12-20046_1ex32d2.htm EX-32.2 4495
  Complete submission text file 0001104659-12-077388.txt   5802273

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20120930.xml EX-101.INS 788902
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20120930.xsd EX-101.SCH 53477
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20120930_cal.xml EX-101.CAL 60880
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20120930_def.xml EX-101.DEF 291393
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20120930_lab.xml EX-101.LAB 751703
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20120930_pre.xml EX-101.PRE 372803
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 121198883
SIC: 2834 Pharmaceutical Preparations